Dr. Nedal Safwat Is Named Chief Strategy Officer of Accelerate Diagnostics

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

Dr. Nedal Safwat has been named chief strategy officer of Accelerate Diagnostics.

Dr. Nedal Safwat joins Accelerate from BioMerieux, the world’s leading microbiology diagnostics company.

Jack Phillips, President and Chief Executive Officer of Accelerate Diagnostics, commented, “We are excited to add a leader to our team with such extensive commercial and operational experience in the microbiology diagnostics space.  In this newly created position as Chief Strategy Officer, Nedal will take a leadership role in the implementation of our recently launched new product strategy and will be responsible for driving the expansion of this strategy over the long term.  I am confident that his experience in the microbiology industry and commitment to growth make him a great fit for our team as we continue to execute against our long-term vision for Accelerate Diagnostics.”

“I am thrilled to join Accelerate Diagnostics, as the company plays a critical role in delivering high medical value tests that are transforming the standard of care.  In my new role, I look forward to working with the Accelerate team to continue delivering products that drive better clinical outcomes for patients, reinforce antibiotic stewardship, and lower the overall cost of the treatment of serious infections,” said Dr. Safwat.

Dr. Nedal Safwat brings significant experience in the microbiology diagnostics and life sciences industries.  During his 11 years at BioMerieux, he held a variety of roles of increasing importance, including positions in sales, product management, global marketing, and, most recently, leading the ID/AST Franchise. Prior to joining BioMerieux, Dr. Safwat held positions at Luminex Corporation, Strategic Diagnostics Incorporated, Miltenyi Biotec Incorporated, and Bayer Diagnostics.

Dr. Safwat received his bachelor’s and doctorate degrees in biochemistry from North Carolina State University.  He is also an alumni of CEDEP (The European Centre for Executive Development).

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.